Anti-parasitic drug Ivermectin kills COVID-19 within 48 hrs in lab grown cells

▴ Ivermectin drug
Ivermectin: an anti-parasitic drug kills coronavirus in 48 hours
An anti-parasitic drug has found to kill COVID-19 in the laboratory within 48 hours. The drug has always been available throughout the world.
A team of Australian scientists at Monash University in Melbourne has shown a single dose of the Ivermectin drug was able to stop the SARS-CoV2 virus growing in cell culture. The Food and Drug Agency approves the drug as an anti-parasitic drug that is effective in fighting viruses such as HIV, influenza, and Zika. Their study was published in the journal Antiviral Research.
Ivermectin: the anti-parasitic drug
Dr. Kylie Wagstaff of Monash University and one of the authors of the study said that they found out that a single dose could remove all viral RNA of COVID-19 within 48 hours and that even in the first 24 hours, there was already a significant reduction in it.
While Ivermectin is known to work on the virus, the drug, however, reduces the host cells' ability to clear the infection. Scientists identified the next step is to determine the correct human dosage so as not to harm humans.
Although COVID-19 has only been known to exist for a few months, the good is that some of the team involved in studying the vaccine already had prior experience and knowledge working with it.
One of the virologists who was part of the team that first isolate and share COVID-19 outside of China in January of this year, Dr. Leon Caly, is excited about the prospect of Ivermectin as a potential drug against COVID-19. Caly is the study's author and senior virus identification specialist from the Victorian Infectious Diseases Reference Laboratory.
Dr. Wagstaff said, "In times when we're having a global pandemic, and there isn't an approved treatment if we had a compound that was already available around the world, then that might help people sooner."Of course, finding a vaccine and cure to this pandemic would take a while to be broadly available. But first, funding for the research is needed before Ivermectin can be used to combat coronavirus.
Tags : #Ivermectin #Antiparasitic #Coronavirus #48hrs

Related Stories

Loading Please wait...


Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023